A phase II randomised study comparing the clinical benefit between Paclitaxel (Taxol) and oral Vinorelbine (Navelbine) in patients with stage IIIBw - IV non-small cell lung cancer (NSCLC), performance status (PS) 2
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Paclitaxel (Primary) ; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.